IP Verse

Compositions, Suitable For Oral Administration, Comprising A Triazolo [4, 5 D]Pyrimidin Derivate - EP2056832

PATENT ANALYSIS

Patent Details

Grant Date
Mar 22, 2017
Company
ASTRAZENECA AB
Oppositions

GENERICS [UK] LIMITED (TRADING AS MYLAN)

HEXAL AG

WITTKOPP, ALEXANDER

More patents of Astrazeneca Ab

EP3045466

EP4114465

EP2508188

Want to monitor this patent?

Feel free to send us a message here and we will get back to you